Speakers

Prasad Adusumilli is a thoracic surgeon-scientist and Vice Chair of Translational Research in Dept. of Surgery at the Memorial Sloan Kettering Cancer Center, New York. His research focuses on solid tumor immunology and immunotherapy. Supported by R01 and Dept of Defense awards, his laboratory...

Sonia Appel has over 20 years of experience in Technical Operations, from commercial molecular diagnostics to pharmaceutical early development.  With a Master of Science in Molecular Biology and a Project Management Professional (PMP) certification, she has led multiple development strategies, IND ...

Brian Avanzino is Director of Discovery Research at Rondo Therapeutics where he leads teams focused on the discovery and development of novel multispecific antibodies for the treatment of solid tumors. Previously, he was at Amgen and Teneobio where he led and advanced several T cell engager...

Aniket Badkar has extensive experience in the pharmaceutical industry, with a focus on biologics drug substance and drug product formulation development. Aniket currently holds the position of Director of Formulation and Drug Product Development at Vir Biotechnology, Inc. In this role, they lead...

Julio Baez is a seasoned bioprocessing scientist, manager and university instructor with a 45 years industrial experience providing a strong background in bringing innovative biologics from discovery to manufacturing. Currently serving at the University of California San Diego and MiraCosta...

Dr. Prasun Chakraborty is the CEO and Founder of Genevation/GeneevationUS, a groundbreaking biotechnology company pioneering the development of personalized cancer vaccines. Dr Chakraborty is a visionary leader and innovator in the field of biotechnology, specializing in the development of...

Dr. Jake Y. Chen, Triton Endowed Professor of Biomedical Informatics and Data Science at UAB School of Medicine, is a Fellow of ACMI and a leading innovator in AI-driven drug discovery. As founding director of the Systems Pharmacology AI Research Center (SPARC) and Contact MPI of the NIH...

Dr. Qiang “Shawn” Chen is a molecular biologist who specializes in developing novel human therapeutics and vaccines in plants to combat infectious diseases, cancer, and biological warfare reagents. His research aims to ameliorate diseases and improve human health, as well as to contribute new...

Mark is the Chief Scientific Officer at Tavotek Biotherapeutics.  He has nearly 35 years of experience in new drug discovery for AbbVie/Abbott Laboratories and Janssen. Prior to joining Tavotek, Dr. Chiu was the Head of the Process Analytical Sciences at Biotherapeutics Development and Head of...

Brandon J. DeKosky joined the Department of Chemical Engineering as an assistant professor in a newly introduced joint faculty position between the department and the Ragon Institute of MGH, MIT and Harvard in September 2021. He received his BS in chemical engineering from University of Kansas, and ...

Dr. Vaibhav Deokar is Principal Scientist at Formulation Development Team of R&D, Lupin Limited (Biotech Division), India. He has pursued M.Tech (Bioprocess Technology) from the Institute of Chemical Technology (ICT) (formerly UDCT), Mumbai and completed his doctoral research under Lupin’s...

Hans van der Vliet, M.D., Ph.D. is a professor in medical oncology at the Amsterdam UMC in the Netherlands. He received his medical doctor degree from the University of Amsterdam in 1998, his doctor of philosophy degree (cum laude) from the VU University in Amsterdam in 2003, and was trained in...

Robert O. Dillman, M.D., is a Clinical Professor of Medicine at the University of California, Irvine, and since 2016 has been the Chief Medical Officer for AIVITA Biomedical Inc., Irvine, CA. For 25 years, he directed the Hoag Cancer Center in Newport Beach, CA, where he directed a cell biology...

Dr Anselm Ebert, PhD holds the position of Business Development Director at H&T Presspart. Dr Ebert oversees the strategic management of the new product development process and manages new product introductions for H&T Presspart. Before joining H&T Presspart he was Director of Product...

Dr. Kamal Egodage serves as the President of Lasanth® Consulting. In this capacity, he provides expert consultation and execution in biologics full Chemistry, Manufacturing, and Controls (CMC) development, regulatory strategy, and interactions with health authorities, spanning from discovery...

Gordon Freeman, PhD, Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School, is renowned for discovering the PD-L1 and PD-L2 proteins. Dr. Freeman showed that PD-L1 and PD-L2 bound to PD-1 to turn off the immune response and that blockade of PD-L1/PD-1 enhanced immune...

Ana Garcia is a Process Development Engineer II in the Viral Production Core team of the Preclinical Manufacturing and Process Development group at Regeneron Pharmaceuticals. In this role Ana contributes to the development of purification processes for rAAV therapies at the 2L, 50L, and 500L...

Dr. Gee is Vice President, Head of Research at 3T Biosciences. He is co-founder of 3T Biosciences and an internationally recognized expert and pioneer in the field of pHLA targeting via T cell receptors and bispecific T cell engagers. Dr. Gee brings more than a decade of domain expertise across the ...

I currently lead clinical development for broadly neutralizing monoclonal antibodies (bnAbs) for HIV prevention--an approach also known as passive immunization or passive immunoprophylaxis. At the HIV Vaccine Trials Network (HVTN), we work closely with partners to develop bnAbs as a new class of...

Davis Goodnight is a Senior Scientist in Platform R&D at A-Alpha Bio, where he works in developing platform technologies to generate massive protein-protein interaction datasets and leveraging these datasets for a variety of therapeutic protein engineering efforts. He earned his Ph.D. in...

Ana Isabel Gutiérrez joined H&T Presspart in 2023 as Global Business Development Manager driving the company’s innovative Parenteral Applications Program. Before joining H&T Presspart, Ana spent over 12 years at West Pharmaceutical Services, where she held a prominent sales leadership...

Dr. Holm serves as a Senior Pharmacist Contract Portfolio Manager within Supply Chain Management at Mayo Clinic, where she negotiates contracts on behalf of Mayo Clinic and Captis, an LLC under Vizient. She drives the development and management of key initiatives focused on contracting...

Laurent Humeau, Ph.D. Chief Scientific Officer; Chairman, Scientific Advisory Board As Chief Scientific Officer, Dr. Humeau works to ensure continuous and strategic growth of INOVIO’s pipeline by introducing a constant flow of innovative concepts and cycling them from early-stage discovery and...

Clayton Irvine is the Senior Manager of Oncology Cancer Care Pharmacy at the Mayo Clinic in Rochester, Minnesota, where he leads daily pharmacy operations within the Mayo Clinic Cancer Center. Clayton currently serves as an appointed committee member for the ASHP Section of Pharmacy Practice...

Zoran Krunic, Senior Manager of Data Science, Amgen   Since joining Amgen R&D in 2018, Zoran Krunic has been at the forefront of applying Machine Learning to enhance patient outcomes and streamline clinical trial enrollment processes, utilizing comprehensive Electronic Health Records and...

I. My Story in a NutshellSince my birth, I have lived around the globe (Tanzania, Singapore, Thailand, Chile, USA, etc.), got my higher educational degrees in USA, and later joined the University of Tokyo as faculty in the Department of Bioengineering. My past achievements include my original...

Sanghoon Lee is an assistant professor in the Department of Computer Science at Kennesaw State University. He received a doctoral degree in computer science from Georgia State University and was a recipient of the Brain & Behavior fellowship at the Neuroscience Institute and the Second Century...

My academic training began in 1998 as an undergraduate at UBC, where I immersed myself in the Combined Honours Physics and Mathematics Program, graduating as a Canada Scholar and recipient of the CK Choi Presidential Award. In 2002, I moved to UC Berkeley as an NSERC fellow to pursue doctoral...

Mengyue (J.P.) Li – Biography With domestic and international experience across higher education, banking, healthcare, and venture capital (VC) & private equity (PE), J.P. embarked on his first entrepreneurial journey by acquiring and scaling a local business in Houston, Texas. Under his...

Dr. Huilan Lin is a bioprocess development scientist with over 10 years of experience in antibody, vaccine, and exosome process development and manufacturing. His work focuses on upstream and downstream process optimization and technology transfer to GMP facilities, and he has contributed to...

Cate Lockhart, PharmD, PhD is the Chief Science Officer of the Academy of Managed Care Pharmacy (AMCP) and the Executive Director of the Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) where she is responsible for all AMCP research programs, including those within the BBCIC...

Dr. Mark Mamula is Professor of Medicine, Yale University School of Medicine, and Founder of TheraJan, LLC (therajan.com), a company developing canine cancer immunotherapies.  Dr. Mamula’s interests are in investigating the early events of inflammatory mediated changes in the proteome that...

Jay Mandrekar, Ph.D., is the primary statistician for Mayo Clinic's Department of Neurology, Department of Surgery, and the Divisions of Infectious Diseases and Clinical Microbiology. He is involved in multiple clinical trials, population-based studies and research grants in these...

Amy MargoliesIntegrative Resilience Coach | Founder, Sunshine Theory Amy Margolies is a breast cancer survivor, former Google executive, and integrative health and resilience coach who brings a powerful, lived-experience perspective to the evolving conversation around biologics, survivorship, and...

Shamekka Marty is a Cybersecurity Project Management Consultant, Foundation Director, and board member of several charitable organizations. She is a dedicated wife, mother of three, Lupus survivor, and mentor, whose advocacy has touched many lives across the globe. Her caregiving journey began at...

Chris Mason MD, PhD, FRSB, FRCS, FMedSciChris has over 30 years of cell and gene therapy experience spanning R&D, clinical medicine, manufacturing, and commercialization. He is a Full Professor of Cell & Gene Therapy at University College London. Chris is also a serial...

Rushabh Mehta is a data-driven supply chain strategist and Financial Analyst at Hammerton Inc., where he merges Artificial Intelligence, Data Science, and Financial Analytics to unlock agility and resilience across complex manufacturing and logistics ecosystems. His work has led to...

Dr. Santosh A. Misal is a Staff Scientist at the National Institutes of Health (NIH) in Bethesda, Maryland, USA. His extensive expertise in protein biochemistry, proteomics, and mass spectrometry advances groundbreaking research in malaria vaccine development. By employing advanced proteomics...

Liviu Movileanu has received his Ph.D. degree in biophysics from the University of Bucharest (1997). He has acquired postdoctoral positions at the University of Missouri (Kansas City, Missouri, 1997-1998) and the Texas A&M University Health Science Center (College Station, Texas, 1999-2004). He ...

Savita Nair, Ph.D., is an accomplished scientist and Associate Director at Sangamo Therapeutics, where she leads the CMC Bioassay Analytical Development group within Technical Operations in Brisbane, California. With a focus on product quality characterization, she has successfully guided her team...

After being diagnosed with a brain cancer (meningioma) and p1RCC (a rare kidney cancer) in 2014, Bill co-founded rarekidneycancer.org with Dr. James Hsieh in 2016.  In 2018 and 2020, with Pete Kane, he brought together 17 teams of more than 80 researchers who used his medical data to determine...

Michael is the technical lead of computational biology at Biolojic Design, where he leads the development of new computational tools for antibody discovery.  Prior to joining Biolojic Design, he worked as a researcher in the Hebrew University of Jerusalem and in the University of...

Kamal Puri is a seasoned executive with a strong background in biotechnology and pharmaceuticals. As the Chief Scientific Officer at OncoResponse, he leads the company's efforts in developing innovative therapies for cancer treatment. With over 25 years of experience in the biotech...

Brandon T. Ruotolo is currently a Professor in the Department of Chemistry, University of Michigan. He earned his B.S. in Chemistry from Saint Louis University in 1999. Brandon then received his Ph.D. from Texas A&M University in 2004 under the direction of David H. Russell. He did his...

Volker Schellenberger co-founded Amunix in 2006 and served as Chief Scientific Officer. He is the lead inventor of the company’s XTEN as well as XPAT platforms of protease-activated T cell engagers. Since the acquisition of Amunix by Sanofi in 2022, Volker directed discovery at Sanofi’s center of...

PRISM was founded in 2009 by Dr. Schnitzer, a world-renowned expert in vascular biology with almost four decades of research experience.  Upon earning his MD in 1985 from the University of Pittsburgh, he served as a Post-Doctoral Fellow in the Department of Cell Biology, Yale University Medical...

Dr. Alessandro Sette has devoted more than 35 years in biotech and academia to understanding and measuring immune responses, and developing disease intervention strategies against cancer, autoimmunity, allergy, and infectious diseases.  Dr. Sette’s laboratory is the world leader in the study of the ...

Jae Sly is a seasoned biopharmaceutical executive and consultant with over 20 years of experience spanning R&D to clinical development. She specializes in strategic partnering and international expansion of biopharma technologies and services, with a strong track record of supporting startups...

Adeleh Taghi Khani is an accomplished scientist with over five years of experience in Immunology and immunogenicity, specializing in therapeutic areas like oncology and autoimmunity. Currently a Scientist II at Quest Diagnostics, she excels in developing immunogenicity assays and strategies, and...

Dr. Keenan Taylor is a Principal Research Scientist I at AbbVie in the Protein Science group within Biotherapeutics and Genetic Medicine. He is responsible for the construct design, purification, and delivery of research-grade proteins/antigens to advance the Biologics Discovery pipeline.

Andrew Tsourkas, Ph.D. is a Professor and Undergraduate Chair of Bioengineering at the University of Pennsylvania.  He received his Bachelor’s degree in Mechanical Engineering in 1997 from Cornell University and his Ph.D. in Biomedical Engineering from the Georgia Tech/Emory University joint...

I am a Senior Scientist at ScopeSys and one of the leads in R&D. Our work sits at the crossroads of chemistry, physics, biology, and therapeutics, utilizing our unique tether-free imaging platform—Convex Lens-induced Confinement (CLiC). We are passionate about studying single nanoparticle...

Dr. XingXing Zang received his M.Med from Shanghai Jiao Tong University School of Medicine and PhD from the University of Edinburgh and completed postdoctoral training with Jim Allison at UC Berkeley and Memorial Sloan-Kettering Cancer Center. He is currently a Professor, the Louis Goldstein Swan...

Dr. Yue Zhao earned her Ph.D in Biochemistry and Molecular Biology from Peking Union Medical School, China. Her graduate work discovered the NOD-like receptors(NAIPs) for recognizing cytosolic bacterial pathogens. She continued working in the innate immunity space and made several phenomenal...

Dr. Zhao has almost 20 years of experience in biomarker research and drug development in both academic and industry settings. She earned her Ph.D. in Bioinformatics from the University of Oslo, Norway, with a focus on breast cancer genomics. During her post-doctoral training at Stanford...

Dr. Yu Zhou is a highly skilled Manager in Analytical Development specializing in viral vectors for cell and gene therapy as well as oncolytic virotherapy within the Life Science division at Millipore Sigma. Prior to joining Millipore Sigma, she spent six years at Novartis, focusing on gene and...